Institutional racism within the medical field and the treatment of people from lower socioeconomic communities plays a large role in racial and ethnic inequities, explained Vivienne Hau, MD, clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine.
Institutional racism within the medical field and the treatment of people from lower socioeconomic communities plays a large role in racial and ethnic inequities, explained Vivienne Hau, MD, clinical assistant professor with the Kaiser Permanente Bernard J. Tyson School of Medicine.
Transcript
What are some of the root causes of racial and ethnic inequities in ophthalmological care?
Now this can be a little bit of a loaded question, but what it really comes down to is that there is much institutionalized racism within the medical field in itself. Now, people in positions of power have been making decisions that negatively impacted health of vulnerable communities for centuries. And a lot of it comes down to just how we treat some of these lower socioeconomic communities that many times are those of underrepresented minorities, as well.
And so, there's things such as housing insecurities, chronic preventable health issues, employment or insurance issues, and so these are affecting their abilities to get access to care, and also for increasing representation as physicians as well, Because if these people are not having just the basis and the foundations to excel and succeed within schooling and education, then they can't become, you know, physicians just like myself and be in those positions of power and help out.
So, because of all of that it affects those abilities to have access to care, and ultimately, to ophthalmological care, as well. And so those are some of the things that we need to look at more. We need to step away and look at the overall picture and how everything ties into things.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
Expanding Access to NSCLC Innovations: Challenges and Opportunities
October 18th 2024The current research focus for Umit Tapan, MD, Boston Medical Center, is reducing disparities in lung cancer care and improving treatment access, in particular for immunotherapy and targeted treatments.
Read More